4//SEC Filing
Washburn Theodore James Jr. 4
Accession 0001439222-25-000011
CIK 0001439222other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:06 PM ET
Size
24.4 KB
Accession
0001439222-25-000011
Insider Transaction Report
Form 4
Washburn Theodore James Jr.
Principal Accounting Officer
Transactions
- Sale
Common stock
2025-03-03$35.54/sh−697$24,771→ 7,691 total - Sale
Common stock
2025-03-03$35.54/sh−727$25,838→ 9,414 total - Award
Restricted stock units
2025-03-01+8,085→ 8,085 total→ Common stock (8,085 underlying) - Exercise/Conversion
Restricted stock units
2025-03-01−777→ 0 total→ Common stock (777 underlying) - Exercise/Conversion
Common stock
2025-03-01+777→ 6,269 total - Exercise/Conversion
Common stock
2025-03-01+2,350→ 8,388 total - Exercise/Conversion
Restricted stock units
2025-03-01−2,350→ 2,350 total→ Common stock (2,350 underlying) - Sale
Common stock
2025-03-03$35.54/sh−231$8,210→ 6,038 total - Exercise/Conversion
Common stock
2025-03-01+2,450→ 10,141 total - Award
Restricted stock units
2025-03-01+6,142→ 6,142 total→ Common stock (6,142 underlying) - Exercise/Conversion
Restricted stock units
2025-03-03−2,450→ 4,900 total→ Common stock (2,450 underlying)
Footnotes (10)
- [F1]Includes 55 shares purchased through the Company's employee stock purchase plan.
- [F10]The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.
- [F3]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
- [F4]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
- [F5]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F6]The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F7]The restricted stock units were granted on March 1, 2025. On February 1, 2027, the shares underlying the restricted stock units will vest in full.
- [F8]The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F9]The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001874199
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:06 PM ET
- Size
- 24.4 KB